Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
OTLK — Outlook Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →

Q3 2024 Earnings Call Summary

AUG 14, 2024
REVENUE
$0
EPS
$1.91 +123.8%
FREE CASH FLOW
-$19.5M -1.3%

No summary has been written for this call yet.